|3.36||-0.07 / -2.04%|
As of 4:00pm ET
|3.36||-0.0004 / -0.01%|
The 1 analysts offering 12-month price forecasts for Galectin Therapeutics Inc have a median target of 16.00, with a high estimate of 16.00 and a low estimate of 16.00. The median estimate represents a +376.19% increase from the last price of 3.36.
The current consensus among 1 polled investment analysts is to Buy stock in Galectin Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.